SENSEX
NIFTY
GOLD
USD/INR

Weather

image 28    C

Economy News

The Economic Times

Economy / The Economic Times

details

Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say

Dr Reddy's Laboratories is poised to launch its generic semaglutide injection, potentially named Obeda, in India by March. This move anticipates the March 2026 patent expiry for the active ingredient in Novo Nordisk's Ozempic and Wegovy. The Indian drugmaker plans competitive pricing, aiming to capture a significant share of the growing diabetes and obesity market.

25 Feb 2026 1:32 pm